Related Experiment Video

Updated: Jun 4, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Receptor tyrosine kinases and their activation in melanoma

David J Easty1, Steven G Gray, Kenneth J O'Byrne

  • 1Department of Oncology, St James's Hospital, Dublin, Ireland  Division of Biomedical Sciences, St George's, University of London, London, UK. david.easty@ucd.ie

Pigment Cell & Melanoma Research
|February 16, 2011
PubMed

Insights

Receptor tyrosine kinases (RTKs) are crucial in melanoma. New technologies reveal mutated RTKs and complex signaling, aiding targeted drug development for melanoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Receptor tyrosine kinases (RTKs) and downstream pathways are implicated in melanoma development.
  • Previous evidence relied on animal models and limited molecular studies.
  • Hypotheses regarding RTK overexpression, activity, and mutations in melanoma were largely unverified.

Purpose of the Study:

  • To comprehensively investigate the role of RTKs and protein tyrosine phosphatases (PTPs) in melanoma.
  • To leverage advanced technologies for a clearer understanding of aberrant signaling in melanoma.
  • To identify druggable targets for novel melanoma therapies.

Main Methods:

  • Utilized advanced gene sequencing techniques.
  • Employed small interfering RNA (siRNA) methods for gene silencing.
  • Analyzed global RTK activity using phospho-RTK arrays.

Main Results:

  • Identified mutated RTK genes (e.g., KIT, ERBB4, EPH, FGFR) in melanoma.
  • Documented altered expression and activity of various RTKs and PTPs.
  • Elucidated complex RTK-PTP interactions driving melanoma cell growth and survival.

Conclusions:

  • RTK and PTP dysregulation is central to melanoma pathogenesis.
  • Understanding these signaling networks is vital for melanoma treatment.
  • Characterizing RTK activity supports the rational design of tyrosine kinase inhibitors for clinical application.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...